Clinical trials and NHS data show that substantial weight loss can bring type 2 diabetes into remission, including in younger adults. But remission is not a cure, and continued monitoring is essential.
Type 2 diabetes remission means blood sugar levels fall below the diabetes threshold without the use of glucose-lowering medication and stay there for at least three months. An international consensus statement published by the American Diabetes Association, the European Association for the Study of Diabetes, Diabetes UK and the Endocrine Society set that definition in 2021, and it also stressed that remission is not the same as a cure. The condition can return if weight is regained or metabolic health worsens, so ongoing follow-up remains important.
That distinction matters because remission describes a period in which the disease is inactive, not eradicated. Experts prefer the term because the underlying biological changes may still be present, even when glucose readings improve. The consensus report says people who reach remission should still have regular checks for diabetes-related complications, since years of raised blood sugar may have already affected the eyes, kidneys, feet and blood vessels.
One of the main reasons remission can happen is the way excess fat accumulates in the liver and pancreas. In his twin-cycle hypothesis, researcher Roy Taylor argues that long-term energy surplus leads to fat build-up in the liver, which makes insulin work less effectively and drives up glucose output, while fat in the pancreas can impair insulin-producing beta cells. Substantial weight loss can reduce that organ fat and restore better glucose control in some people.
The strongest evidence for this approach comes from the DiRECT trial, published in The Lancet. That study used a structured programme built around temporary withdrawal of diabetes medication, a total diet replacement plan delivering roughly 825 to 853 calories a day, and gradual food reintroduction with support to maintain weight loss. At one year, remission became much more common as weight loss increased: about 34% of participants who lost 5 kg to 10 kg achieved remission, rising to 57% among those who lost 10 kg to 15 kg and 86% among those who lost at least 15 kg.
Real-world NHS data point in the same direction. England’s Type 2 Diabetes Path to Remission programme, which offers a closely supervised low-calorie diet replacement plan and help with weight maintenance, reported that 32% of completers with the required measurements were in remission after a year. The average weight loss among those participants was nearly 16 kg. Eligibility is limited to people aged 18 to 65, diagnosed within the previous six years and not using insulin, reflecting the fact that remission is more likely when diabetes is caught early and beta-cell function is less impaired.
A newer study suggests the same strategy may also help younger adults with early-onset diabetes. The RESET for Remission trial, presented at the European Association for the Study of Diabetes annual meeting and published in The Lancet Regional Health – Americas, followed 96 adults aged 18 to 45 with obesity in England and Canada. Those assigned to a 12-week low-energy diet, plus supervised aerobic and resistance exercise, and then a weight-maintenance phase, had a 54% remission rate at 24 weeks, compared with 4% in usual care. The trial reported mainly mild side-effects that eased over time, although the researchers said longer follow-up is still needed.
The evidence also shows that remission is not always permanent. In DiRECT, many participants regained some weight over time, and the share in remission fell after the first year. The longer-term follow-up reported by the trial team found that around a quarter of those who were in remission at year two were still in remission at year five. Even so, the programme was associated with fewer serious medical events requiring hospital admission, suggesting that periods of remission can still deliver meaningful health benefits even when they are not lifelong.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
